Efficacy and Safety of Eslicarbazepine Acetate as Monotherapy for Patients With Newly Diagnosed Partial-onset Seizures
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy and safety of eslicarbazepine
acetate (BIA 2-093) as monotherapy for patients with newly diagnosed partial-onset seizures.